Search by Drug Name or NDC
NDC 15370-0130-02 RyVent 6 mg/1 Details
RyVent 6 mg/1
RyVent is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Carwin Pharmaceutical Associates, LLC. The primary component is CARBINOXAMINE MALEATE.
Product Information
NDC | 15370-0130 |
---|---|
Product ID | 15370-130_0e84f4a5-7637-6b55-e063-6294a90a4d55 |
Associated GPIs | 41200010150325 |
GCN Sequence Number | 077160 |
GCN Sequence Number Description | carbinoxamine maleate TABLET 6 MG ORAL |
HIC3 | Z2P |
HIC3 Description | ANTIHISTAMINES - 1ST GENERATION |
GCN | 43082 |
HICL Sequence Number | 004483 |
HICL Sequence Number Description | CARBINOXAMINE MALEATE |
Brand/Generic | Brand |
Proprietary Name | RyVent |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | carbinoxamine maleate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 6 |
Active Ingredient Units | mg/1 |
Substance Name | CARBINOXAMINE MALEATE |
Labeler Name | Carwin Pharmaceutical Associates, LLC |
Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA207484 |
Listing Certified Through | 2025-12-31 |
Package
NDC 15370-0130-02 (15370013002)
NDC Package Code | 15370-130-02 |
---|---|
Billing NDC | 15370013002 |
Package | 2 TABLET in 1 BOTTLE, PLASTIC (15370-130-02) |
Marketing Start Date | 2017-02-17 |
NDC Exclude Flag | N |
Pricing Information | N/A |